Search Results 941-950 of 15520 for fecal microbiota transplant
That call — and the successful kidney-liver transplant that occurred two days later — were the turning point in Anglemyer's search for a cure for hyperoxaluria,.
Croome KP, Subramanian V, Mathur AK, Aqel B, Mao SA, Clendenon JN, Perry DK, Dhanireddy K, Taner CB. Outcomes of DCD Liver Transplant Using Sequential ...
The goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic ...
The new system is expected to widen the donor pool, thus getting more donor hearts to more recipients. Mayo Clinic teams have performed heart transplants using ...
The purpose of this study is to compare the effectiveness of rejection surveillance of heart transplant recipients with Prospera dd-cfDNA to rejection ...
Share · Tweet . VID-20208275. Home; Brightcove-Transplant Center. Fund research. Save lives. Give Today. Benefactor support fuels Mayo Clinic's ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. Transplantation. 2008 Apr 27; 85(8):1212-5. View ...
... transplant. Bone Marrow Transplant. 2019 Nov; 54 ... Fecal Samples. ... Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion ...
Utilizing kidneys from a donor with bile-cast nephropathy. Am J Transplant. 2024 Jan; 24(1):141-144. Epub 2023 Aug 25. View PubMed; Punukollu R, Ohara SY, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.